- $828.27m
- $2.23bn
- $2.07bn
- 80
- 88
- 82
- 97
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,204 | 1,534 | 1,848 | 1,889 | 2,069 |
Cost of Revenue | |||||
Gross Profit | 274 | 292 | 358 | 336 | 436 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,136 | 1,539 | 1,766 | 1,949 | 1,969 |
Operating Profit | 68.7 | -5.23 | 82.9 | -60.3 | 100 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 31.1 | -54.2 | 37.5 | -123 | -18.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 20 | -45.5 | 28.4 | -133 | -46.7 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 504 | -26.3 | -3.25 | -180 | -86.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 504 | -26.3 | -3.25 | -180 | -86.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.203 | -0.126 | 0.308 | -0.693 | -0.388 |